Synaptophysin Test
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Synaptophysin Test</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SYP-TEST</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Synaptophysin Test</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=SYP-TEST" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/epilepsy" style="color:#ef9a9a">Epilepsy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td>
</tr>
</table>
Synaptophysin (SYP) is a major synaptic vesicle protein and widely used neuronal marker in neurobiology and neurodegenerative disease research. This page provides comprehensive information about its structure, function, role in synaptic transmission, and implications in Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
Overview
...Synaptophysin Test
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Synaptophysin Test</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SYP-TEST</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Synaptophysin Test</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=SYP-TEST" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/epilepsy" style="color:#ef9a9a">Epilepsy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td>
</tr>
</table>
Synaptophysin (SYP) is a major synaptic vesicle protein and widely used neuronal marker in neurobiology and neurodegenerative disease research. This page provides comprehensive information about its structure, function, role in synaptic transmission, and implications in Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
Overview
Synaptophysin is one of the most abundant synaptic vesicle proteins, constituting up to 10% of the total synaptic vesicle protein content [1]. It is encoded by the SYP gene located on chromosome Xp11.23 and serves as a critical marker for presynaptic terminals and neuronal viability. Due to its abundant expression and specific localization to synaptic vesicles, synaptophysin is extensively used as a immunohistochemical marker for synaptic density and nerve terminal integrity in both research and clinical diagnostic settings. [@selkoe2002]
Structure
Synaptophysin is a 338-amino acid integral membrane protein with four transmembrane domains and both N- and C-termini facing the cytoplasm. The protein forms homo-oligomeric complexes that create channels in the synaptic vesicle membrane, facilitating the transport of small molecules and ions. [@masliah1990]
Function
Synaptic Vesicle Biogenesis
Synaptophysin plays a fundamental role in synaptic vesicle biogenesis and maintenance. It interacts with other synaptic proteins including synaptogyrin, SV2, and synapsins to regulate vesicle formation, loading, and trafficking. [@csf2024]
Neurotransmitter Release
Synaptophysin regulates neurotransmitter release through its involvement in synaptic vesicle exocytosis and endocytosis. Studies using synaptophysin knockout mice demonstrate altered synaptic vesicle release kinetics, indicating its role in modulating quantal content and synaptic efficacy [2]. [@lacor2007]
During neural development, synaptophysin expression correlates with synaptogenesis. The protein is essential for proper synaptic connectivity and undergoes activity-dependent modifications that influence synaptic plasticity. [@cheng2023]
Disease Associations
Alzheimer's Disease
Synaptophysin is significantly downregulated in Alzheimer's disease (AD) brains, correlating with cognitive decline [3]. Loss of synaptophysin-immunoreactive presynaptic terminals is one of the earliest pathological changes in AD, preceding neuronal loss. [@bellucci2024]
- Synaptic loss in AD: Masliah et al. demonstrated significant reduction in synaptophysin immunoreactivity in AD [hippocampus](/brain-regions/hippocampus), correlating with memory deficits [3].
- Biomarker potential: CSF synaptophysin levels are being investigated as a biomarker for synaptic degeneration in AD [4].
- Relationship to amyloid: Synaptic dysfunction induced by [amyloid-beta](/proteins/amyloid-beta) oligomers includes alterations in synaptophysin expression and distribution [5].
Parkinson's Disease
In Parkinson's disease (PD), synaptophysin levels are reduced in the substantia nigra and other affected brain regions [6]. The loss of dopaminergic nerve terminals can be monitored using synaptophysin immunohistochemistry.
- Synaptic [α-synuclein](/proteins/alpha-synuclein): Interaction between synaptophysin and α-synuclein may contribute to synaptic dysfunction in PD [7].
Other Neurodegenerative Diseases
- Lewy body dementia: Synaptophysin loss in cortical regions correlates with cognitive symptoms
- Frontotemporal dementia: Reduced synaptophysin in frontal and temporal cortices
- Huntington's disease: Early synaptic alterations include synaptophysin changes
Diagnostic Applications
Histopathology
Synaptophysin immunohistochemistry is widely used to assess synaptic density in post-mortem brain tissue. It serves as a sensitive marker for detecting synaptic loss in neurodegenerative diseases, differentiating between disease subtypes, and assessing disease progression.
Biomarker Development
CSF synaptophysin and synaptic vesicle glycoprotein 2 (SV2) are being developed as fluid biomarkers for synaptic degeneration. Lower CSF synaptophysin correlates with worse cognitive performance in AD.
Therapeutic Implications
Drug Development
Synaptophysin and synaptic proteins are emerging as therapeutic targets. Synaptic-protective compounds are being developed to preserve nerve terminals, and gene therapy approaches aim to restore synaptic function.
Monitoring Treatment Response
Synaptophysin levels can serve as a pharmacodynamic marker for disease-modifying therapies targeting synaptic protection and anti-amyloid immunotherapies.
Research Methods
Immunohistochemistry
Synaptophysin antibodies are used in standard immunohistochemistry on formalin-fixed tissue, immunofluorescence for confocal microscopy, ELISA-based quantification of CSF levels, and Western blot analysis of brain tissue.
Animal Models
Synaptophysin knockout mice exhibit reduced synaptic vesicle number, altered neurotransmitter release, and learning and memory deficits.
Cross-References
- [Synaptic dysfunction in Alzheimer's disease](/synaptic-dysfunction-in-alzheimer's-disease)
- [NMDA receptor](/entities/nmda-receptor)
- [Biomarkers in Alzheimer's disease](/mechanisms/biomarkers-alzheimers)
- [Phosphorylated tau217](/biomarkers/p-tau217)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [Amyloid-beta plaques](/mechanisms/amyloid-pathology)
See Also
- [Synaptophysin (SYP) Gene](/genes/synaptophysin)
- [Synaptic Proteins](/content/proteins)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [GeneCards: SYP](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYP) - Gene information
- [UniProt: P08240](https://www.uniprot.org/uniprot/P08240) - Protein information
- [PubMed: Synaptophysin](https://pubmed.ncbi.nlm.nih.gov/?term=synaptophysin+Alzheimer) - Research literature
References
[Unknown, Wiedenmann B, Franke WW. Identification of a major synaptic vesicle protein of the mammalian brain. Cell. 1985;41(3):1017-1028 (1985)](https://pubmed.ncbi.nlm.nih.gov/2411542/))
[Unknown, Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298(5594):789-791 (2002)](https://pubmed.ncbi.nlm.nih.gov/11988770/))
[Masliah E, et al., Quantitative immunohistochemical analysis of synaptic markers in Alzheimer's disease. Ann Neurol. 1990;27(5):457-464 (1990)](https://pubmed.ncbi.nlm.nih.gov/2164718/))
[Unknown, CSF synaptic biomarkers in AD. Nat Aging. 2024;4:894-906 (2024)](https://pubmed.ncbi.nlm.nih.gov/39476256/))
[Lacor PN, et al., Synaptic targeting by amyloid-beta oligomers. J Neurosci. 2007;27(44):11881-11889 (2007)](https://pubmed.ncbi.nlm.nih.gov/22582591/))
[Cheng HC, et al., Synaptic loss and atrophy in Parkinson's disease substantia nigra. J Neural Transm. 2023;130(3):345-357 (2023)](https://pubmed.ncbi.nlm.nih.gov/35649655/))
[Bellucci A, et al., Synucleinopathy: involvement of synaptic proteins. Prog Neurobiol. 2024;234:102601 (2024)](https://pubmed.ncbi.nlm.nih.gov/40993829/))